BCRX vs CAI Stock Comparison

CAI currently leads BCRX in this stock comparison, with AIQ scores of 70 vs 59. The clearest difference is momentum, while BCRX has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 11 points
BCRX
Healthcare
vs
CAI
Healthcare
BCRX
BioCryst Pharmaceuticals, Inc.
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Risk Resilience
Sector
Healthcare
CAI
Caris Life Sciences, Inc.
Leads
Price
$23.04
Day move
-3.84%
AIQ Score
70/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BCRX and CAI?

CAI leads the current stock comparison as Caris Life Sciences, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

BioCryst Pharmaceuticals, Inc. vs Caris Life Sciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

CAI leads

CAI leads by 11 AIQ points, primarily on Momentum and Quality.

Competitive: 4 of 6 evidence groups support CAI, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Stable
BCRX

BioCryst Pharmaceuticals, Inc.

AIQ Score
59/100
AIQ Edge Score
6/10
CAI

Caris Life Sciences, Inc.

Leads
AIQ Score
70/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors CAI over BCRX, 70 versus 59 as of Nov 15, 2026. CAI's advantage is driven primarily by stronger momentum and quality, while BCRX holds the stronger risk resilience profile. CAI also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor CAI today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. CAI lead: Stable — the AIQ differential has held near 11 points over 30 sessions.

Compare BioCryst Pharmaceuticals, Inc. and Caris Life Sciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

BCRX
-23.6%
CAI
-17.7%

Price return comparison

Growth of $10,000, price only

BCRX $7,641 · CAI $8,229

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare BCRX and CAI against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BCRX advantage
0
CAI advantage
  • Momentum42 vs 85
    CAI +43
  • Risk Resilience55 vs 36
    BCRX +19
  • Value86 vs 68
    BCRX +18
  • Quality64 vs 71
    CAI +7

4 of 6 evidence groups favor CAI. CAI’s edge is concentrated in momentum and quality; BCRX keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

CAI0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

CAI's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — BCRX and CAI both carry a full feed there.

The central trade-off

CAI (Caris Life Sciences, Inc.): the stronger current systematic profile, led by momentum and quality.

BCRX (BioCryst Pharmaceuticals, Inc.): the counter-case, on risk resilience, value, valuation.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

CAI

CAI on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CAI

CAI on combined revenue and EPS growth.

Value

BCRX

BCRX on the peer-relative Value factor, by 18 points.

Momentum

CAI

CAI on the Momentum factor, by 43 points.

Lower downside

BCRX

BCRX on Risk Resilience, by 19 points.

Analyst upside

CAI

CAI on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBCRXCAINote
Implied upside to target+44.5%+64.9%CAI has more room
Target dispersion0%0%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1114Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor CAI. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreCAI59 vs 70
FundamentalsCAIrevenue growth -17.4% vs 4.4%; EPS growth -51.6% vs 22.7%; TTM ROE -9.5% vs 2.4%; gross margin 25.3% vs 69.1%; operating margin -30.1% vs 13.4%
ValuationBCRXValue 86 vs 68
TechnicalsCAIPrice vs 50-day -7.6% vs -21.6%; vs 200-day -13.5% vs 6.5%
Risk ResilienceBCRXRisk Resilience 55 vs 36
Analyst expectationsCAITarget upside 44.5% vs 64.9%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCRX and CAI and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 11 points.
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CAI.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

CAI lead: Stable — the AIQ differential has held near 11 points over 30 sessions.

May 27BCRX leads above the line · CAI leads belowNov 13
Today
CAI +11
59 vs 70
7 sessions ago
CAI +10
62 vs 72
30 sessions ago
CAI +11
60 vs 71
90 sessions ago
BCRX +7
71 vs 64

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • Death Cross Active — bearish, trend, long horizon (6.91%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
CAIConflicted

1 bullish / 2 bearish / 2 neutral, conflicted

Only CAI

  • Golden Cross Active — bullish, trend, long horizon (35.85%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

CAI leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

CAINo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -3.84%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BCRX closes the Momentum gap — currently 43 points behind, the largest single contributor to CAI's edge.
  2. 2BCRX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3CAI's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CAI leads on balance
MetricBCRXCAI
Revenue growth (YoY)-17.4%4.4%
EPS growth (YoY)-51.6%22.7%
Gross margin25.3%69.1%
Operating margin-30.1%13.4%
Return on equity (TTM)-9.5%2.4%
Debt to equity-2.080.72

Performance

BCRX leads 4 of 6 windows
MetricBCRXCAI
1 week (5 sessions)-1%-8.7%
1 month (20 sessions)-2.3%-24.6%
3 months (63 sessions)-23.4%6.5%
6 months (126 sessions)-15.6%58.4%
Year to date-2.4%-14.6%
1 year (252 sessions)6%-7%

Technicals

CAI has the stronger structure
MetricBCRXCAI
RSI (14)40.730.9
ADX (14)15.237.3
Price vs 50-day-7.6%-21.6%
Price vs 200-day-13.5%6.5%
Volatility (1M, annualized)45.2%91.7%

Risk

BCRX is the more resilient
MetricBCRXCAI
Beta0.651.85
Sharpe ratio0.360.22
Sortino ratio0.560.31
Max drawdown-32.2%-49.6%
Current drawdown-31.5%-36.2%
Annualized volatility48.1%69.8%
Value at risk (95%)-4.1%-6.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BCRX or CAI?

On the Algovestiq AIQ Score, CAI is the stronger of the two as of Nov 15, 2026, scoring 70 against BCRX's 59. The edge comes from momentum and quality. BCRX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BCRX or CAI the better buy right now?

CAI carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor CAI over BCRX?

The composite weights Quality, Value, Momentum and Risk Resilience. CAI leads Momentum by 43 points; BCRX leads Risk Resilience by 19 points; BCRX leads Value by 18 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BCRX or CAI?

Analyst price targets imply +44.5% upside for BCRX and +64.9% for CAI, so the Street currently favors CAI. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BCRX or CAI?

BCRX is the better-valued of the two on the peer-relative Value factor. BCRX on the peer-relative Value factor, by 18 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BCRX or CAI?

CAI on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BCRX or CAI?

CAI on the Momentum factor, by 43 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BCRX or CAI?

BCRX is the more resilient of the two, so the other name carries the higher downside risk. BCRX on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BCRX more profitable than CAI?

CAI leads on the comparable margin measures — gross margin 25.3% vs 69.1%; operating margin -30.1% vs 13.4%; ttm roe -9.5% vs 2.4%.

Is CAI's lead over BCRX getting stronger or weaker?

CAI lead: Stable — the AIQ differential has held near 11 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BCRX vs CAI verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BCRX closes the Momentum gap — currently 43 points behind, the largest single contributor to CAI's edge; BCRX's Death Cross Active resolves — a bearish trend rule currently active against it; CAI's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BCRX and CAI?

BCRX: 0 bullish / 2 bearish / 2 neutral. CAI: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCRX is Death Cross Active (bearish, long horizon). On CAI it is Golden Cross Active (bullish, long horizon).

Compare BCRX and CAI with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.